Comment
. 1995 May 27;345(8961):1372; author reply 1374-5.
ISIS-4
- PMID: 7752783
Item in Clipboard
Comment
ISIS-4
Lancet.
.
No abstract available
Comment on
-
ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group.Lancet. 1995 Mar 18;345(8951):669-85. Lancet. 1995. PMID: 7661937 Clinical Trial.
Similar articles
-
Acute myocardial infarction, reperfusion injury, and intravenous magnesium therapy: basic concepts and clinical implications.Am Heart J. 1996 Aug;132(2 Pt 2 Su):478-82; discussion 496-502. doi: 10.1016/s0002-8703(96)90339-7. Am Heart J. 1996. PMID: 8694007 Review.
-
ISIS-4.Lancet. 1995 May 27;345(8961):1373; author reply 1374-5. Lancet. 1995. PMID: 7752786 No abstract available.
-
ISIS-4.Lancet. 1995 May 27;345(8961):1372; author reply 1374-5. Lancet. 1995. PMID: 7752784 No abstract available.
-
ISIS-4.Lancet. 1995 May 27;345(8961):1372-3; author reply 1374-5. Lancet. 1995. PMID: 7752785 No abstract available.
-
The rationale of magnesium as alternative therapy for patients with acute myocardial infarction without thrombolytic therapy.Am Heart J. 1996 Aug;132(2 Pt 2 Su):483-6; discussion 496-502. doi: 10.1016/s0002-8703(96)90340-3. Am Heart J. 1996. PMID: 8694008 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
